ChemicalBook > CAS DataBase List > 9-Nitrominocycline

9-Nitrominocycline

Product Name
9-Nitrominocycline
CAS No.
149934-16-7
Chemical Name
9-Nitrominocycline
Synonyms
9-Nitro Minocycline;Tigecycline Impurity G;Tigecycline Impurity 12;GEGDTZYTPKKFGB-IRDJJEOVSA-N;TigecyclineImpurity12Hemisulfate;(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino);Minocycline Impurity 5(Minocycline 9-Nitro Impurity);Minocycline EP Impurity G Intermediate(9-Nitro Minocycline);Minocycline Impurity 5 Hemisulfate(Minocycline 9-Nitro Impurity Hemisulfate);Minocycline 9-Nitro ImpurityQ: What is Minocycline 9-Nitro Impurity Q: What is the CAS Number of Minocycline 9-Nitro Impurity
CBNumber
CB32622575
Molecular Formula
C23H26N4O9
Formula Weight
502.47
MOL File
149934-16-7.mol
More
Less

9-Nitrominocycline Property

Boiling point:
825.9±65.0 °C(Predicted)
Density 
1?+-.0.1 g/cm3(Predicted)
pka
4.50±1.00(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

9-Nitrominocycline Chemical Properties,Usage,Production

Uses

9-Nitrominocycline is used as a reagent in the preparation of tigecycline from minocycline hydrochloride.

Uses

9-Nitrominocycline is a 9-substituted Minocycline (M344800) derivative used as antibacterial agent.

Indications

Minoxidil, an antihypertensive agent, produces arteriolar vasodilation by an unknown mechanism. In limited clinical studies, minoxidil increases penile rigidity and has been used in the long-term treatment of organic impotence.

Biological Functions

Minoxidil (Loniten) is an orally effective vasodilator. It is more potent and longer acting than hydralazine and does not accumulate significantly in patients with renal insufficiency. It depends on in vivo metabolism by hepatic enzymes to produce an active metabolite, minoxidil sulfate. Minoxidil sulfate activates potassium channels, resulting in hyperpolarization of vascular smooth muscle and relaxation of the blood vessel.

Pharmacology

The hemodynamic effects of minoxidil are generally similar to those of hydralazine, with the noteworthy exception that a greater decrease in peripheral vascular resistance and consequently a larger reduction in blood pressure can be achieved with minoxidil. Minoxidil produces no important changes in either renal blood flow or glomerular filtration rate. It has little or no effect on venous capacitance and does not inhibit the reflex activation of the sympathetic nervous system. Orthostasis and other side effects of sympathetic blockade are therefore not a problem. As with hydralazine, there is a significant increase in cardiac output that is secondary to reflex increases in sympathetic activity, hyperreninemia, and salt and water retention.These effects can substantially reduce the effectiveness of minoxidil when it is used alone.The addition of a -blocker and a diuretic to the therapeutic regimen will preserve minoxidil’s antihypertensive action while attenuating some of the undesirable side effects.

Clinical Use

The major indications for the use of minoxidil are (1) severe hypertension that may be life threatening and (2) hypertension that is resistant to milder forms of therapy. Compromises in renal function do not prolong either the plasma or the therapeutic half-life of minoxidil, and therefore, it seems to be particularly important for hypertensive patients with chronic renal failure.

Side effects

Signs of toxicity common to vasodilator therapy in general also occur with minoxidil; they are attributable to vasodilation and reflex increases in sympathetic nerve activity. These include headache, nasal congestion, tachycardia, and palpitations. These effects do not have great clinical importance, since minoxidil is almost always administered in combination with a -blocker, which antagonizes the indirect cardiac effects. A more troublesome side effect, particularly in women, is the growth of body hair, possibly due to a direct stimulation of the growth and maturation of cells that form hair shafts. Apparently, minoxidil activates a specific gene that regulates hair shaft protein. In any case, this particular side effect has been capitalized upon, and minoxidil is now marketed as Rogaine for the treatment of male pattern baldness.

Metabolism

Peak concentrations of minoxidil in the blood occur 1 hour after oral administration, although the therapeutic effect may take 2 or more hours to manifest. This is probably related to the time it takes to convert minoxidil to minoxidil sulfate. The antihypertensive action after an oral dose of minoxidil lasts 12 to 24 hours. The long duration of action allows the drug to be administered only once or twice a day, a regimen that may be beneficial for compliance. Interestingly, the therapeutic half-life is considerably longer than the plasma half-life. This may be, as has been suggested for hydralazine, a result either of accumulation of the drug and its active metabolite in arterial walls or a longer plasma half-life of the sulfated metabolite, or both.
The ultimate disposition of minoxidil depends primarily on hepatic metabolism and only slightly on renal excretion of unchanged drug. Because of this, pharmacological activity is not cumulative in patients with renal failure.

9-Nitrominocycline Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

9-Nitrominocycline Suppliers

Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15402
Advantage
60
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
18070
Advantage
56
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Fax
QQ:2853117752
Email
3003392093@qq.com
Country
China
ProdList
8705
Advantage
55
Alchemist-pharm chemical Technology Co. Ltd.
Tel
0371-67991738 13783628208
Fax
QQ 412703949
Email
carl@alchemist-pharm.com
Country
China
ProdList
1872
Advantage
58
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 +86-13028896684;
Email
sales@rrkchem.com
Country
China
ProdList
57423
Advantage
58
Guangzhou Dreampharm Biotechnology Co., Ltd.
Tel
020-36607679 17825480238
Fax
QQ 3008233717
Email
3008233746@qq.com
Country
China
ProdList
9919
Advantage
12
Standardpharm Co. Ltd.
Tel
86-714-3992388
Email
overseasales1@yongstandards.com
Country
United States
ProdList
14332
Advantage
58
Jinan blalong chemical co. LTD
Tel
2710913286@.com
Email
1513643261@qq.com
Country
China
ProdList
14246
Advantage
58
Cato Research Chemicals Inc.
Tel
020-81215950 4000-868-328
Email
customer@uwalab.com
Country
United States
ProdList
10404
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing1@energy-chemical.com
Country
China
ProdList
44806
Advantage
58

149934-16-7, 9-NitrominocyclineRelated Search:


  • Tigecycline Impurity G
  • (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)
  • Tigecycline Impurity 12
  • (4S,4aS,5aR,12aS)-4,7-Bis(diMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxaMide
  • [4S-(4α,4aα,5aα,12aα)]-4,7-Bis(diMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxaMide
  • 9-Nitro Minocycline
  • GEGDTZYTPKKFGB-IRDJJEOVSA-N
  • Minocycline Impurity 5(Minocycline 9-Nitro Impurity)
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • Minocycline 9-Nitro ImpurityQ: What is Minocycline 9-Nitro Impurity Q: What is the CAS Number of Minocycline 9-Nitro Impurity
  • Minocycline EP Impurity G Intermediate(9-Nitro Minocycline)
  • (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
  • TigecyclineImpurity12Hemisulfate
  • Minocycline Impurity 5 Hemisulfate(Minocycline 9-Nitro Impurity Hemisulfate)
  • 149934-16-7
  • Amines
  • Aromatics
  • Intermediates & Fine Chemicals
  • Pharmaceuticals